Luminex Corporation Fourth Quarter and Year-End 2006 Earnings Release Scheduled for February 7, 2007
25 January 2007 - 2:00AM
PR Newswire (US)
AUSTIN, Texas, Jan. 24 /PRNewswire-FirstCall/ -- Luminex
Corporation (NASDAQ:LMNX) today announced that it expects to report
fourth quarter and year-end 2006 results on Wednesday, February 7,
2007. Results are scheduled for release after the close of trading.
Management will hold a conference call to discuss the operating
highlights and financial results for the fourth quarter and year
ended December 31, 2006, on February 8, 2007, at 8:00 a.m. Eastern
time. The conference call will be webcast live and will be
accompanied by a slide presentation, both of which may be accessed
at Luminex Corporation's website at http://www.luminexcorp.com/.
Simply log on to the web at the address above, go to the Company
section and access the Investor Relations link. Please go to the
website at least 15 minutes prior to the call to register, download
and install any necessary audio/video software. If you are unable
to participate during the live webcast, the call and slides will be
archived for one year on the website using the 'replay' link. The
use of pop-up blocking software may impair your ability to view
webcasts. If you use this software, press and hold the CTRL key
when you click on the Register button. Please contact your IT group
if you are unable to override this feature. Unauthorized recording
or downloading of this event is not permitted. Luminex Corporation
develops, manufactures and markets proprietary biological testing
technologies with applications throughout the life sciences
industry. The Company's xMAP(R) system is an open-architecture,
multi-analyte technology platform that delivers fast, accurate and
cost-effective bioassay results to markets as diverse as
pharmaceutical drug discovery, clinical diagnostics and biomedical
research, including the genomics and proteomics research markets.
The Company's xMAP(R) technology is sold worldwide and is in use in
leading research laboratories as well as major pharmaceutical,
diagnostic and biotechnology companies. Further information on
Luminex Corporation or xMAP(R) can be obtained on the Internet at
http://www.luminexcorp.com/. Statements made in this release that
express Luminex's or management's intentions, plans, beliefs,
expectations or predictions of future events are forward-looking
statements. The words "believe," "expect," "intend," "estimate,"
"anticipate," "will," "could," "should" and similar expressions are
intended to further identify such forward-looking statements for
purposes of the Private Securities Litigation Reform Act of 1995.
It is important to note that the Company's actual results or
performance could differ materially from those anticipated or
projected in such forward-looking statements. Factors that could
cause Luminex's actual results or performance to differ materially
include risks and uncertainties relating to, among others, market
demand and acceptance of Luminex's products, the Company's
dependence on strategic partners for development, commercialization
and distribution of products, concentration of the Company's
revenue in a limited number of strategic partners, fluctuations in
quarterly results due to a lengthy and unpredictable sales cycle
and bulk purchases of consumables, Luminex's ability to scale
manufacturing operations and manage operating expenses, gross
margins and inventory levels, potential shortages of components,
competition, the timing of regulatory approvals, the
implementation, including any modification, of the Company's
strategic operating plans, risks and uncertainties associated with
implementing our acquisition strategy and the ability to integrate
acquired companies or selected assets into our consolidated
business operations, as well as the risks discussed under the
heading "Risk Factors" in Luminex's Reports on Forms 10-K and 10-Q,
as filed with the Securities and Exchange Commission. The
forward-looking statements contained herein represent the judgment
of Luminex as of the date of this press release, and Luminex
expressly disclaims any intent, obligation or undertaking to
release publicly any updates or revisions to any forward- looking
statements to reflect any change in Luminex's expectations with
regard thereto or any change in events, conditions or circumstances
on which any such statements are based. Contact: Harriss T. Currie
Vice President, Finance and Chief Financial Officer 512-219-8020
DATASOURCE: Luminex Corporation CONTACT: Harriss T. Currie, Vice
President, Finance and Chief Financial Officer of Luminex
Corporation, +1-512-219-8020, Web Site: http://www.luminexcorp.com/
Copyright
Luminex (NASDAQ:LMNX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Luminex (NASDAQ:LMNX)
Historical Stock Chart
From Jul 2023 to Jul 2024